Skip to content
★ Sign in to follow
HC

Hospital Corporation of China Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$464.1MHealth Care

1 insider bought shares over the last 90 days, the latest by Liu Lu, filed 27 Oct 2026.

Hospital Corporation of China Ltd.: what insiders have been doing

Hospital Corporation of China Ltd. belongs to the Health Care sector. Filings by its managers are published through HKEX. 1 insider has disclosed 10 filings since 27 October 2025.

On the market, 1 insider bought (1 purchase) while 1 insider sold (9 sales totalling €47k). The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a sale of €15k from Liu Lu, disclosed on 27 October 2026. Among those who bought: 1 senior executive.

The last purchase on record was published on 27 October 2026, which is 12 days ago. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

Compared with its exchange (1,318 companies, median 4 filings), a count of 10 filings is above the norm. Since 2017, the database holds 5 purchases and 11 sales by insiders of the company.

In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.

Insider Decl.
17
Thresholds
n/a
Buy Volume
€136M
5 ops. · all time
Sell Volume
€46,811
11 ops. · all time

Who traded when

BuySale
Liu Lu9 sales

Since the insiders bought

  • Filed 10 Aug 2018 · 3012 days ago · €84.9M
    -33.3%
    Entry HK$18.00 · Close at T+365 HK$12.00
  • Filed 27 Oct 2017 · 3299 days ago · €2.7M
    +21.7%
    Entry HK$13.64 · Close at T+365 HK$16.60

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 5,079 of 26,897 companies
67.7
score / 100
Value
95
Quality
40
FCF yld29%
Earn yld30%
EV/EBITDA4.4x
ROE1.7%
Gross mgn18%
Net mgn9.3%
Debt/EBITDA3.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$3.40
Analyst consensus
·
Income statement
RevenueHK$1.5B
Gross profitHK$267.6M18% margin
EBITDAHK$350.9M24% margin
Net incomeHK$136.4M-0.1% margin
Valuation
P/Book0.7x
Beta-0.31
Balance sheet & cash
Market capHK$464.1M
Total debtHK$1.1B
Free Cash FlowHK$135.7M
Debt / Equity131%
Profitability & ownership
ROE1.7%
ROA3.7%
% institutions76.7%
Last declaration on 27 October 2026
Declarations17 total
  • ▼
    DirectorExecutives
    8,256 HKD0HKEX
    1,200 shares@ HK$6.88ShareXHKGHKEX:DA20261027E00078
  • ▼
    DirectorExecutives
    13,760 HKD0HKEX
    2,000 shares@ HK$6.88ShareXHKGHKEX:DA20261027E00077
  • ▼
    DirectorExecutives
    24,768 HKD0HKEX
    3,600 shares@ HK$6.88ShareXHKGHKEX:DA20261027E00076
  • ▼
    DirectorExecutives
    22,016 HKD0HKEX
    3,200 shares@ HK$6.88ShareXHKGHKEX:DA20261027E00075
  • ▼
    DirectorExecutives
    8,256 HKD0HKEX
    1,200 shares@ HK$6.88ShareXHKGHKEX:DA20261027E00074
  • ▼
    DirectorExecutives
    137,600 HKD0HKEX
    20,000 shares@ HK$6.88ShareXHKGHKEX:DA20261027E00073
  • ▼
    DirectorExecutives
    137,600 HKD0HKEX
    20,000 shares@ HK$6.88ShareXHKGHKEX:DA20261027E00072
  • ▼
    DirectorExecutives
    15,100 HKD0HKEX
    2,000 shares@ HK$7.55ShareXHKGHKEX:DA20261027E00071
  • ▼
    DirectorExecutives
    57,792 HKD0HKEX
    8,400 shares@ HK$6.88ShareXHKGHKEX:DA20261027E00070
  • ▲
    DirectorExecutives
    0HKEX
    9,098,800 sharesShareXHKGHKEX:DA20261027E00069
    Canonical exit: 5 Jun 2018 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    24,876 sharesShareXHKGHKEX:DA20210128E00403
    Canonical exit: 5 Jun 2018 (T+90)
  • ▼
    DirectorExecutives
    0HKEX
    2,500,000 sharesShareXHKGHKEX:DA20200123E00553
  • ▲
    DirectorExecutives
    774M HKD17HKEX
    38,693,985 shares@ HK$20.0063.7% of flowShareXHKGHKEX:DA20180810E00036
    Canonical exit: 5 Nov 2018 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    4,587,425 sharesShareXHKGHKEX:DA20180528E00044
  • ▲
    DirectorExecutives
    468M HKD15HKEX
    26,000,000 shares@ HK$18.0036.3% of flowShareXHKGHKEX:DA20180129E00315
    Canonical exit: 25 Apr 2018 (T+90)
  • ▲
    DirectorExecutives
    25M HKD19HKEX
    1,727,425 shares@ HK$14.35100.0% of flowShareXHKGHKEX:DA20171027E00191
    Canonical exit: 22 Jan 2018 (T+90)
  • ▼
    DirectorExecutives
    0HKEX
    6,412,201 sharesShareXHKGHKEX:DA20171026E00431

17 of 17 declarations

About Hospital Corporation of China Ltd.

Hospital Corporation of China Ltd. is a company operating in the healthcare sector, specializing in the management and operation of hospitals in China. It is listed on the Hong Kong Stock Exchange.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations